Video Experimental Relacionado

Updated: Jul 10, 2026

A Protocol for Analyzing Hepatitis C Virus Replication

A Protocol for Analyzing Hepatitis C Virus Replication

Published on: June 26, 2014

Hacia una vacuna contra el virus de la hepatitis C

Anna Offersgaard^1,2, Jens Bukh^1,2, Judith M Gottwein^1,2

¹Copenhagen Hepatitis C Program (CO-HEP), Department of Infectious Diseases, Copenhagen University Hospital Hvidovre, Hvidovre, Denmark.

Science (New York, N.Y.)

|April 6, 2023

Resumen

Se están desarrollando nuevas vacunas para prevenir enfermedades hepáticas crónicas. Estos avances ofrecen la esperanza de reducir la carga de las enfermedades hepáticas.

Área de la Ciencia:

Hepatología
Inmunología
Vacunas y vacunas

Sus antecedentes:

Las enfermedades hepáticas crónicas representan un importante desafío para la salud mundial.
Las opciones actuales de tratamiento para las enfermedades hepáticas crónicas son limitadas.
Las estrategias preventivas, como la vacunación, son muy deseables.

Objetivo del estudio:

Revisar los avances recientes en el desarrollo de vacunas para enfermedades hepáticas crónicas.
Para destacar el potencial de las nuevas vacunas candidatas.

Principales métodos:

Revisión de las publicaciones científicas recientes.
Análisis de los datos preclínicos y clínicos de las vacunas contra enfermedades hepáticas.

Principales resultados:

Están surgiendo varias vacunas prometedoras dirigidas a la hepatitis viral y otras patologías hepáticas.
Los avances en la inmunotecnología están permitiendo diseños de vacunas más efectivos.

Conclusiones:

El desarrollo de vacunas es muy prometedor para la prevención de enfermedades hepáticas crónicas.
La investigación y la inversión continuas son cruciales para traducir estos avances en la práctica clínica.

Más Videos Relacionados

Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle

Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle

Published on: February 1, 2017

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks

Published on: June 26, 2020

Videos de Conceptos Relacionados

Cytomegalovirus Disease

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...

Hepatitis

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...

Inhibitors of Viral Protein Synthesis

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...

Inhibitors Of Virion Release

Inhibitors Of Virion Release

Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...

Antiviral Nucleoside Inhibitors

Antiviral Nucleoside Inhibitors

Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...

Viral Hepatitis I: Introduction

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...